Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 09, 2025 10:46 ET | Source: Research and Markets

Pharmaceuticals and Biotechnology Joint Venture Agreements Analysis Report 2025 with Directory of Deals Signed Since 2016 Featuring 623 Companies

Dublin, May 09, 2025 (GLOBE NEWSWIRE) -- The "Joint Venture Deals in Pharmaceuticals and Biotechnology 2016-2025" report has been added to ResearchAndMarkets.com's offering.Joint Venture Deals in...
May 08, 2025 14:15 ET | Source: UTR Therapeutics Inc.

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancers

UTR Therapeutics Inc Announces IND submission to the US FDA for a First-in-Human Clinical Trial of an mRNA destabilizing drug targeting c-MYC driven cancer
May 07, 2025 08:15 ET | Source: Avance Clinical

Avance Clinical Sponsors Prestigious Citeline Awards 2025 To Recognize Innovative Biotechnology Companies

Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025 tomorrow in Boston.
April 22, 2025 11:00 ET | Source: Verified Market Research

Cell Counting Market is expected to generate a revenue of USD 16.5 Billion by 2031, Globally, at 6.20% CAGR: Verified Market Research®

Lewes, Delaware, April 22, 2025 (GLOBE NEWSWIRE) -- The Global Cell Counting Market Size is projected to grow at a CAGR of 6.20% from 2024 to 2031, according to a new report published by Verified...
April 22, 2025 04:59 ET | Source: Research and Markets

South Korea Drug Development Trends Report 2025: Focus on Early R&D and CGT Puts South Korea at the Forefront of Drug Development

Dublin, April 22, 2025 (GLOBE NEWSWIRE) -- The "Drug Development Trends in South Korea" report has been added to ResearchAndMarkets.com's offering.South Korea has become a significant player in the...
April 17, 2025 04:31 ET | Source: Research and Markets

Analytical Standards Market Research 2025 - Global Forecast to 2030: Raw Material Testing to Maintain Largest Share in Analytical Standards Methodology

Dublin, April 17, 2025 (GLOBE NEWSWIRE) -- The "Analytical Standards Market by Technique (GC, LC, TLC, IR, MS, NMR, Titrimetry), Category (Organic, Inorganic), Method (Bioanalytical, Dissolution),...
April 15, 2025 04:28 ET | Source: Research and Markets

Al in Biotechnology Markets, 2029: Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, RWE, Inventory, Supply Chain, Logistics; Launch, Pricing, Patient Engagement, Adverse Events

Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "Al in Biotechnology Market by Function (Drug Design & Optimisation, Biomarker, SAR; Clinical Trial Design, Data Assessment, RWE, Inventory, Supply...
April 14, 2025 08:15 ET | Source: Certara

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
April 10, 2025 16:33 ET | Source: Odylia Therapeutics

Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event

BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day...
April 08, 2025 07:57 ET | Source: ZyVersa Therapeutics

ZyVersa Therapeutics CEO Issues Shareholder Letter on PARASOL Recommendations Expected to Reduce Drug Development Barrier for Rare Kidney Disease, Focal Segmental Glomerulosclerosis (FSGS)

Parasol group recommended reduction in proteinuria over 24 months as a surrogate endpoint for full approval of FSGS drugs.

Next Page keyboard_arrow_right